{Reference Type}: Journal Article
{Title}: Salivary Interleukin-1 Levels in Oral Squamous Cell Carcinoma: A Case-Control Study.
{Author}: Vala D;Shah J;Purba AK;Mehta T;Mansata AV;Almalki SA;Makkad RS;
{Journal}: J Pharm Bioallied Sci
{Volume}: 16
{Issue}: 0
{Year}: 2024 Feb
暂无{DOI}: 10.4103/jpbs.jpbs_558_23
{Abstract}: <B>UNASSIGNED: </B>Oral squamous cell carcinoma (OSCC) is a prevalent malignancy with a significant impact on global health. The identification of non-invasive biomarkers for early detection and monitoring of OSCC remains crucial.<BR><B>UNASSIGNED: </B>A total of 100 subjects, comprising 50 patients with histopathologically confirmed OSCC and 50 age- and sex-matched healthy controls, were enrolled in the study. Salivary samples were collected from all participants and analyzed using enzyme-linked immunosorbent assays (ELISA) to measure IL-1 levels. Clinical data, including demographic information, smoking habits, and alcohol consumption, were obtained from patient records.<BR><B>UNASSIGNED: </B>The mean salivary IL-1 level was significantly higher in OSCC patients compared to healthy controls (P < 0.001). Furthermore, subgroup analysis demonstrated that advanced stages of OSCC correlated with significantly elevated IL-1 levels when compared to early-stage OSCC (P < 0.05). Additionally, high salivary IL-1 levels were associated with a more aggressive tumor phenotype and poorer prognosis, as reflected by tumor size, lymph node metastasis, and overall survival (P < 0.01).<BR><B>UNASSIGNED: </B>This case-control study provides compelling evidence that salivary Interleukin-1 (IL-1) levels are significantly elevated in patients with OSCC.